Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 03-2012 | 09-2011 | 09-2010 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 0 | 7,970 | 0 |
| Marketable Securities | 0 | 16,490 | 0 |
| Receivables | 0 | 260 | 0 |
| Other current assets | 0 | 370 | 0 |
| TOTAL | $0 | $25,090 | $0 |
| Non-Current Assets | |||
| PPE Net | N/A | 5,160 | N/A |
| Other Non-Current Assets | 0 | 460 | 0 |
| TOTAL | $N/A | $5,620 | $N/A |
| Total Assets | $0 | $26,090 | $0 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 0 | 560 | 0 |
| Accrued Expenses | 0 | 1,580 | 0 |
| TOTAL | $0 | $2,140 | $0 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 0 | 1,990 | 0 |
| TOTAL | $N/A | $1,990 | $N/A |
| Total Liabilities | $0 | $4,140 | $0 |
| Shareholders' Equity | |||
| Common Shares | 0 | 10 | 0 |
| Retained earnings | 0 | -131,970 | 0 |
| Other shareholders' equity | 0 | 153,910 | 0 |
| TOTAL | $0 | $21,950 | $0 |
| Total Liabilities And Equity | $0 | $26,090 | $0 |